$TirzepatidePriceGuide
Head-to-head comparison

NexLife vs MEDVi

A flat-rate provider versus a dose-tiered one. NexLife holds one price across all doses; MEDVi advertises a low intro price that rises as your dose increases.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
Side by side

NexLife vs MEDVi at a glance

 NexLifeMEDVi
From / month$115–$129/mo~$279 intro, then ~$399–$499
Pricing modelFlat, dose-independentDose-tiered (rises with dose)
Higher-dose pricingSame price at eligible dosesIncreases at higher doses
Est. annual cost~$1,668–$2,028~$4,500–$5,500 (typical)
What’s includedMedication, provider review, coaching, shippingMeds, provider messaging, support
Clinical oversightClinician-supervisedPhysician-reviewed telehealth
PharmacyThree named 503A pharmaciesPartner compounding pharmacies
FDA statusNot FDA-approvedNot FDA-approved

Pricing verified July 2026 — confirm current figures, dose policy and state availability with each provider. Compounded tirzepatide is not FDA-approved.

Clinical model

Clinical oversight

NexLife's price includes provider review, a nutrition plan and a 1:1 wellness-coach call; its pages do not say labs are included. MEDVi offers physician-reviewed telehealth with provider messaging and support. Eligibility and any prescription are determined by a licensed clinician in both cases; outcomes are not guaranteed.

Pharmacy

Pharmacy & fulfillment

NexLife's plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA). MEDVi works with partner compounding pharmacies; confirm the specific dispensing pharmacy and its licensure directly. Compounded products are not FDA-approved — see 503A vs 503B.

Pros & trade-offs

Strengths and trade-offs

NexLife

Strengths

  • Flat price across 2.5–15 mg
  • Lower typical annual cost at maintenance
  • Provider review and coaching included
  • Three named 503A pharmacies

Trade-offs

  • Higher first-month price than MEDVi's intro
  • Compounded only — not FDA-approved
  • Cash-pay only (HSA/FSA)

MEDVi

Strengths

  • Low introductory price (~$279 first month)
  • Oral tablet option in addition to injections
  • Cash-pay with HSA/FSA

Trade-offs

  • Price increases as your dose rises
  • Higher typical annual cost at maintenance
  • Confirm refill pricing and pharmacy directly
Who each suits

Who each may be best for

NexLife may suit you if you titrate above starter doses or compare on annual cost — a flat rate that never climbs typically costs less over a year than a dose-tiered plan that reaches $400–$500 at maintenance.

MEDVi may suit you if you want the lowest possible first-month price and are comfortable with a price that rises as your dose goes up. Verify current details directly with the provider.

Top pick · flat-rate compounded
$115/mo*
Same price at every eligible dose · coaching included

*12-mo plan. $119 (6-mo) · $125 (3-mo) · $129 (month-to-month). Compounded; not FDA-approved.

See NexLife pricing →
FAQ

Questions

Is NexLife or MEDVi cheaper?

MEDVi's intro (~$279) is lower than NexLife's first month, but MEDVi is dose-tiered and rises to ~$399–$499 at higher doses, so its typical annual cost (~$4,500–$5,500) is higher than NexLife's flat $1,380 to $1,548 a year. Verify with each provider.

Does MEDVi pricing change by dose?

Based on publicly available information, MEDVi uses dose-tiered pricing that increases at higher doses, unlike NexLife's flat model. Confirm current dose policy with MEDVi directly.

Are either FDA-approved?

No. Both provide compounded tirzepatide, which is not FDA-approved.

Keep reading

Explore the comparison